Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,850 | 13,160 | 14,460 | 15,740 | 16,810 |
| Marketable Securities | 260 | 540 | 230 | 1,010 | 1,550 |
| Other current assets | 490 | 780 | 590 | 410 | 200 |
| TOTAL | $12,600 | $14,480 | $15,280 | $17,160 | $18,560 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,630 | 1,610 | 1,610 | 1,410 | 1,410 |
| TOTAL | $1,630 | $1,610 | $1,610 | $1,410 | $1,410 |
| Total Assets | $14,340 | $16,210 | $17,010 | $18,690 | $20,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,410 | 1,920 | 1,760 | 1,330 | 1,070 |
| TOTAL | $2,410 | $1,920 | $1,760 | $1,330 | $1,070 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,410 | $1,920 | $1,760 | $1,330 | $1,070 |
| Shareholders' Equity | |||||
| Common Shares | 170 | 170 | 160 | 160 | 8,160 |
| Retained earnings | -33,260 | -30,050 | -27,820 | -25,650 | -23,880 |
| Other shareholders' equity | 1,870 | 2,500 | 3,240 | 3,260 | 3,270 |
| TOTAL | $11,920 | $14,290 | $15,250 | $17,360 | $19,010 |
| Total Liabilities And Equity | $14,330 | $16,210 | $17,010 | $18,690 | $20,080 |